To determine the incidence and severity of drug induced acute pancreatitis, data from 45 German centres of gastroenterology were evaluated. Among 1613 patients treated for acute pancreatitis in 1993, drug induced acute pancreatitis was diagnosed in 22 patients (incidence 1.4%). Drugs held responsible were azathioprine, mesalazine/sulfasalazine, 2' ,3'-dideoxyinosine (ddI), oestrogens, frusemide, hydrochlorothiazide, and rifampicin. Pancreatic necrosis not exceeding 33% of the organ was found on ultrasonography or computed tomography, or both, in three patients (14%). Pancreatic pseudocysts did not occur. A decrease of arterial P°2 reflecting respiratory insufficiency, and an increase of serum creatinine, reflecting renal insufficiency as complications of acute pancreatitis were seen in two (9%) and four (18%) patients, respectively. Artificial ventilation was not needed, and dialysis was necessary in only one (5%) case. Two patients (9%) died of AIDS and tuberculosis, respectively; pancreatitis did not seem to have contributed materially to their death. In conclusion, drugs rarely cause acute pancreatitis, and drug induced acute pancreatitis usually runs a benign course. (Gut 1995; 37: 565-567) 
Patients and methods To determine the incidence of drug induced pancreatitis, we asked 45 German centres of gastroenterology how many patients they had treated in 1993 for acute pancreatitis and how often the aetiology was drug related. To obtain an impression of disease severity, we further asked for the length of the hospital stay, the occurrence of acute respiratory and renal failure, the development of pancreatic pseudocysts and necroses, and resulting death rate.
All data on drug induced pancreatitis were evaluated by us. We included only those patients for whom the centres had already excluded all other aetiologies, except drugs, which have been shown either in published reports or in the specifically reported patient to reinduce acute pancreatitis on rechallenge, or which are among those -according to previous reports -strongly suspected of inducing acute pancreatitis.3-6 When fatal outcome was reported, we tried to establish whether this resulted from pancreatitis or the underlying disease.
Each centre was responsible for the exclusion of the main aetiologies of acute pancreatitis, namely alcohol and biliary disease, which was done by means of case history given by the patient or his relatives/friends (alcohol) or ultrasound (biliary disease).
Furthermore, all centres were responsible for the diagnosis of acute pancreatitis, which was usually based on typical signs and symptoms, an increase in enzyme activity, and the signs of the disease upon imaging procedures, such as ultrasound and computed tomography, which were asked for.
Results
During the 12 month period of 1993, 1613 patients with acute pancreatitis had been treated by the 45 participating centres of gastroenterology. Alcoholism was the most prevalent aetiology, followed by biliary tract disease. Smaller groups had other (post-endoscopic retrograde cholangiopancreatography (ERCP), post-traumatic, postoperative, viral genesis) or unknown aetiologies. In 22 patients (12 female, 10 male, mean age 42, range 19-80 years), drug induced acute pancreatitis was diagnosed, the incidence being 1-4% (Table I) . Drugs considered responsible were azathioprine (n= 6), mesalazine/sulfasalazine (n= 5), 2',3'-dideoxyinosine (ddI) (n=4), oestrogens (n= 3), frusemide (n= 2), and hydrochlorothiazide and rifampicin (n= 1 each) (Table II) Furthermore, all fatal cases after an intake of azathioprine occurred after renal transplantation, and all ddl induced cases coincided with AIDS, both underlying diseases being not infrequently associated with acute pancreatitis. Of the three patients with fatal frusemide pancreatitis, one had a myocardial infarction and the other a cardiac problem, in addition,30 and the third patient was an alcoholic with pancreatic calcifications, a sign of chronic pancreatitis, who died of renal failure in a diabetic coma.31 Three of the five fatal hydrochlorothiazide2 35 cases were treated at a time when modern intensive treatment of acute pancreatitis was unknown.
In accordance with our findings, there are no fatal cases of acute pancreatitis in published reports following mesalazine/sulfasalazine,37-52 oestrogens,53 54 and rifampicin.55
Despite the low incidence and the moderate severity of drug induced acute pancreatitis, all patients with acute pancreatitis ofunknown aetiology should be carefully questioned on drugs possibly responsible for the induction of the disease. In positive cases, the drug held responsible should be omitted to reduce the possibility of further episodes of acute pancreatitis.
